rss
Br J Ophthalmol 82:1249-1253 doi:10.1136/bjo.82.11.1249
  • Original Article
    • Clinical science

Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study

Table 4

Clinical adverse experience summary

Combination (n=151) Concomitant (n=148)
No (%) No (%)
Patients evaluated 151 148
With any adverse experience 72 (48) 76 (51)
Drug related adverse experience 36 (24) 43 (29)
Serious adverse experience 1 (1) 0 (0)
Patients who died 0 (0) 0 (0)
Discontinued owing to adverse experience 2 (1) 1 (1)
  • No significant differences between treatment groups were found.

  • Drug related implies possibly, probably, or definitely caused by the test drug.

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.